Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Bilateral versus unilateral thyroid eye disease.

Kashkouli MB, Kaghazkanani R, Heidari I, Ketabi N, Jam S, Azarnia S, Pakdel F.

Indian J Ophthalmol. 2011 Sep-Oct;59(5):363-6. doi: 10.4103/0301-4738.83612.

PMID:
21836341
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Hyperthyroid vs hypothyroid eye disease: the same severity and activity.

Kashkouli MB, Pakdel F, Kiavash V, Heidari I, Heirati A, Jam S.

Eye (Lond). 2011 Nov;25(11):1442-6. doi: 10.1038/eye.2011.186. Epub 2011 Aug 5.

PMID:
21818129
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Thyroid-associated ophthalmopathy in Iranian patients.

Kashkouli MB, Jam S, Sabzvari D, Ketabi N, Azarinia S, SeyedAlinaghi S, Mofid A.

Acta Med Iran. 2011;49(9):612-8.

PMID:
22052145
[PubMed - indexed for MEDLINE]
Free Article
4.

Age influences the severity of Graves' ophthalmopathy.

Lin MC, Hsu FM, Bee YS, Ger LP.

Kaohsiung J Med Sci. 2008 Jun;24(6):283-8. doi: 10.1016/S1607-551X(08)70154-2.

PMID:
18635413
[PubMed - indexed for MEDLINE]
5.

Clinical evaluation of Graves ophthalmopathy in north-east Islamic Republic of Iran.

Razavi ME, Abotoraby RB, Kakhki RD, Ghanavati SZ, Layegh P, Taghavi M, Rajabian MT.

East Mediterr Health J. 2008 Jul-Aug;14(4):841-9.

PMID:
19166167
[PubMed - indexed for MEDLINE]
6.

Thyroid-associated ophthalmopathy in juvenile Graves' disease--clinical, endocrine and therapeutic aspects.

Krassas GE, Gogakos A.

J Pediatr Endocrinol Metab. 2006 Oct;19(10):1193-206. Review.

PMID:
17172081
[PubMed - indexed for MEDLINE]
7.

Quality of life in patients with thyroid eye disease.

Bahmani-Kashkouli M, Pakdel F, Astaraki A, Hashemi M, Honarbakhsh Y, Mirarmandehi B, Jam S.

J Ophthalmic Vis Res. 2009 Jul;4(3):164-8.

PMID:
23198067
[PubMed]
Free PMC Article
8.

Thyroid volume and severity of Graves' orbitopathy.

Profilo MA, Sisti E, Marcocci C, Vitti P, Pinchera A, Nardi M, Rocchi R, Latrofa F, Menconi F, Altea MA, Leo M, Rago T, Marinò M.

Thyroid. 2013 Jan;23(1):97-102. doi: 10.1089/thy.2012.0379.

PMID:
23088654
[PubMed - indexed for MEDLINE]
9.

The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.

Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B.

Eur J Endocrinol. 2009 Sep;161(3):483-7. doi: 10.1530/EJE-09-0383. Epub 2009 Jun 19.

PMID:
19542244
[PubMed - indexed for MEDLINE]
Free Article
10.

Childhood Graves' ophthalmopathy: results of a European questionnaire study.

Krassas GE, Segni M, Wiersinga WM.

Eur J Endocrinol. 2005 Oct;153(4):515-21.

PMID:
16189172
[PubMed - indexed for MEDLINE]
Free Article
11.

Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.

Kemp EH, Ridgway JN, Smith KA, Watson PF, Weetman AP.

Clin Endocrinol (Oxf). 2000 Sep;53(3):291-9.

PMID:
10971445
[PubMed - indexed for MEDLINE]
12.

Clinical presentation of Graves' ophthalmopathy.

Wiersinga WM, Smit T, van der Gaag R, Mourits M, Koornneef L.

Ophthalmic Res. 1989;21(2):73-82.

PMID:
2786616
[PubMed - indexed for MEDLINE]
13.

Cigarette smoking and thyroid eye disease: a systematic review.

Thornton J, Kelly SP, Harrison RA, Edwards R.

Eye (Lond). 2007 Sep;21(9):1135-45. Epub 2006 Sep 15. Review.

PMID:
16980921
[PubMed - indexed for MEDLINE]
14.

Ophthalmic complications in juvenile Graves' Disease - clinic and therapeutic approaches.

Krassas GE.

Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:223-9; discussion 229. Review.

PMID:
16444162
[PubMed - indexed for MEDLINE]
15.

Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.

Gopinath B, Musselman R, Beard N, El-Kaissi S, Tani J, Adams CL, Wall JR.

Clin Exp Immunol. 2006 Jul;145(1):56-62.

PMID:
16792674
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt.

Laurberg P, Berman DC, Bülow Pedersen I, Andersen S, Carlé A.

J Clin Endocrinol Metab. 2012 Jul;97(7):2325-32. doi: 10.1210/jc.2012-1275. Epub 2012 Apr 19.

PMID:
22518849
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Rituximab in the treatment of thyroid eye disease: science fiction?

Salvi M, Vannucchi G, Campi I, Beck-Peccoz P.

Orbit. 2009;28(4):251-5.

PMID:
19839884
[PubMed - indexed for MEDLINE]
18.

[Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].

Wall JR, Lahooti H.

Endokrynol Pol. 2011;62 Suppl 1:1-7. Review. Polish.

PMID:
22125104
[PubMed - indexed for MEDLINE]
19.

Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?

Maurer E, Dănilă R, Dominguez E, Osei-Agymang T, Zielke A, Hassan I.

Chirurgia (Bucur). 2008 May-Jun;103(3):291-5.

PMID:
18717277
[PubMed - indexed for MEDLINE]
20.

Total thyroidectomy for the treatment of recurrent graves' disease with ophthalmopathy.

Nart A, Uslu A, Aykas A, Yuzbasioglu F, Dogan M, Demirtas O, Simsek C.

Asian J Surg. 2008 Jul;31(3):115-8.

PMID:
18658008
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk